Reactivation rates in patients using biological agents, with resolved HBV infection or isolated anti-HBc IgG positivity

SOLAY A. H., ACAR A., ESER F., KUŞCU F., TUTUNCU E. E., KUL G., ...Daha Fazla

TURKISH JOURNAL OF GASTROENTEROLOGY, cilt.29, sa.5, ss.561-565, 2018 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 29 Sayı: 5
  • Basım Tarihi: 2018
  • Doi Numarası: 10.5152/tjg.2018.18032
  • Dergi Adı: TURKISH JOURNAL OF GASTROENTEROLOGY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, TR DİZİN (ULAKBİM)
  • Sayfa Sayıları: ss.561-565
  • Çukurova Üniversitesi Adresli: Evet

Özet

Background/Aims: Tumor necrosis factor-alpha (TNF-alpha) inhibitors and ustekunimab are widely used in autoimmune diseases. It is known that these biological agents cause the reactivation of hepatitis 8 virus (HBV). There is no standardized strategy to prevent the reactivation in patients with evidence of a previous HBV infection. In our study, anti-HBc IgG-positive patients who received a biological agent were evaluated in terms of HBV reactivation.